Stockscreener 앱 받기
11.62
0.22%
-0.07
전일 마감가:
$11.69
열려 있는:
$11.7
하루 거래량:
442.70K
Relative Volume:
0.27
시가총액:
$3.65B
수익:
$2.68B
순이익/손실:
$-184.45M
주가수익비율:
-17.08
EPS:
-0.6805
순현금흐름:
$229.23M
1주 성능:
+16.64%
1개월 성능:
+10.56%
6개월 성능:
+62.46%
1년 성능:
+37.23%
1일 변동 폭
$11.60
$11.88
1주일 범위
$10.06
$11.88
52주 변동 폭
$6.685
$11.88
Amneal Pharmaceuticals Inc Stock (AMRX) Company Profile
명칭
Amneal Pharmaceuticals Inc
전화
908-947-3120
주소
400 Crossing Boulevard, 3rd Floor, Bridgewater
AMRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMRX
Amneal Pharmaceuticals Inc
|
11.63 | 3.67B | 2.68B | -184.45M | 229.23M | -0.6805 |
|
ZTS
Zoetis Inc
|
120.07 | 53.10B | 9.40B | 2.65B | 2.22B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.59 | 42.93B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.395 | 41.46B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.04 | 28.22B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
448.34 | 19.27B | 3.08B | 1.24B | 1.07B | 25.61 |
Amneal Pharmaceuticals Inc Stock (AMRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-06 | 개시 | Goldman | Buy |
| 2025-02-24 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-09-06 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2021-03-08 | 업그레이드 | Goldman | Sell → Buy |
| 2020-12-14 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-12-14 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-07-27 | 개시 | Goldman | Sell |
| 2020-05-12 | 업그레이드 | Guggenheim | Sell → Neutral |
| 2019-12-12 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-11-12 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2019-11-07 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2019-07-22 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2019-07-11 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-07-08 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2019-06-11 | 개시 | Barclays | Equal Weight |
| 2019-05-21 | 업그레이드 | Raymond James | Mkt Perform → Strong Buy |
| 2019-03-20 | 개시 | SunTrust | Buy |
| 2019-03-08 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2018-12-14 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-16 | 다운그레이드 | SunTrust | Buy → Hold |
| 2018-08-13 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2018-07-23 | 개시 | Morgan Stanley | Overweight |
| 2018-06-22 | 개시 | B. Riley FBR, Inc. | Buy |
모두보기
Amneal Pharmaceuticals Inc 주식(AMRX)의 최신 뉴스
Is Amneal Pharmaceuticals Inc. stock a top momentum playMarket Volume Report & Scalable Portfolio Growth Ideas - newser.com
Is Amneal Pharmaceuticals Inc. stock in correction or buying zoneJuly 2025 Short Interest & AI Powered Market Entry Ideas - newser.com
United States Epinephrine Autoinjector Market 2025: Industry - openPR.com
Real time breakdown of Amneal Pharmaceuticals Inc. stock performanceSell Signal & Technical Analysis for Trade Confirmation - newser.com
Whale Trades: Will Amneal Pharmaceuticals Inc. stock outperform Dow Jones indexWeekly Trade Summary & Daily Momentum Trading Reports - fcp.pa.gov.br
Will Amneal Pharmaceuticals Inc. stock outperform Dow Jones indexJuly 2025 Opening Moves & Stock Market Timing Techniques - newser.com
Is Amneal Pharmaceuticals Inc. stock ready for a breakout2025 Trading Recap & Growth Focused Entry Reports - newser.com
Published on: 2025-11-05 22:21:28 - newser.com
Will Amneal Pharmaceuticals Inc. stock benefit from automationEarnings Recap Summary & Proven Capital Preservation Methods - newser.com
Amneal Pharmaceuticals (NASDAQ:AMRX) Sets New 52-Week HighHere's What Happened - MarketBeat
Implied Volatility Surging for Amneal Pharmaceuticals Stock Options - MSN
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Multi asset correlation models including Amneal Pharmaceuticals Inc.Market Performance Summary & Weekly Setup with High ROI Potential - newser.com
Is Amneal Pharmaceuticals Inc. stock resilient to inflationJuly 2025 Final Week & Fast Gain Stock Tips - newser.com
What analyst consensus says on Amneal Pharmaceuticals Inc. stockQuarterly Earnings Summary & Verified Momentum Stock Ideas - newser.com
Does Amneal Pharmaceuticals Inc. show high probability of reboundQuarterly Risk Review & Weekly Chart Analysis and Trade Guides - newser.com
BioSpace 2026 Best Places to Work Spotlights Most Desirable Workplaces - BioSpace
Will Amneal Pharmaceuticals Inc. stock reach Wall Street targetsQuarterly Market Summary & Daily Price Action Insights - newser.com
Aug Drivers: Is Amneal Pharmaceuticals Inc. stock in correction or buying zone2025 Performance Recap & Smart Investment Allocation Tips - fcp.pa.gov.br
Candlestick signals on Amneal Pharmaceuticals Inc. stock todayJuly 2025 Movers & Daily Stock Trend Reports - newser.com
How high can Amneal Pharmaceuticals Inc. stock goInsider Buying & Weekly Watchlist for Consistent Profits - newser.com
How to manage a losing position in Amneal Pharmaceuticals Inc.Weekly Investment Report & Verified Stock Trade Ideas - newser.com
Published on: 2025-11-02 12:06:47 - newser.com
Amneal Pharmaceuticals Reports Strong Q3 2025 Results - MSN
Amneal Pharmaceuticals Hits New 52-Week High of $10.70 - Markets Mojo
Piper Sandler Reaffirms Overweight Rating for Amneal Pharmaceuticals (NASDAQ:AMRX) - MarketBeat
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Biogen (BIIB), Option Care Health (OPCH) and Amneal Pharmaceuticals (AMRX) - The Globe and Mail
Amneal raises 2025 EPS guidance and outlines $300M–$500M CREXONT sales target as portfolio expansion accelerates - MSN
Amneal Pharmaceuticals stock hits 52-week high at $10.72 By Investing.com - Investing.com Australia
Amneal Pharmaceuticals (AMRX): One-Off $55.9M Loss Tests Bull Case Built on High Earnings Growth Forecasts - Sahm
Amneal Pharmaceuticals, Inc. (AMRX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Amneal Pharmaceuticals (NASDAQ:AMRX) Releases Earnings Results, Beats Estimates By $0.03 EPS - MarketBeat
Why Amneal (AMRX) Stock Is Up Today - Yahoo Finance
Amneal Pharmaceuticals (NASDAQ:AMRX) Reaches New 12-Month High on Strong Earnings - MarketBeat
Amneal Pharmaceuticals stock hits 52-week high at $10.72 - Investing.com
Truist Raises Price Target on Amneal Pharmaceuticals to $14 From $13, Keeps Buy Rating - MarketScreener
Amneal Pharmaceuticals Inc (AMRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
6.71%
0.60%
자본화:
|
볼륨(24시간):